0.293
1.84%
-0.0055
Qualigen Therapeutics Inc Azioni (QLGN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
122.57%
-0.3673
|
1.627 | 1.6072 | 1.3899 | 1.4411 |
Operating Expenses
|
46.34%
2.7784
|
5.1782 | 5.2999 | 10.04 | 5.824 |
Benefits Costs and Expenses |
44.56%
2.8678
|
5.1729 | 5.8782 | 10.19 | 5.4969 |
Costs And Expenses |
44.56%
2.8678
|
5.1729 | 5.8782 | 10.19 | 5.4969 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
21.76%
-2.7784
|
-3.5511 | -3.6928 | -8.6485 | -4.3829 |
Net Interest Income/Expense |
2.69%
-0.3673
|
-0.3774 | -0.5442 | -0.0424 | 0.00463 |
Nonoperating Income/Loss |
8,788%
-0.4567
|
0.00526 | -0.5783 | -0.1542 | 0.3271 |
Income/Loss From Continuing Operations Before Tax |
8.77%
-3.235
|
-3.5459 | -4.271 | -8.8027 | -4.0559 |
Income/Loss From Continuing Operations After Tax |
7.77%
-3.235
|
-3.5077 | -4.1072 | -8.5376 | -4.0559 |
Income/Loss From Discontinued Operations, Net Of Tax |
-0.46
|
- | - | - | - |
Net Income/Loss
|
5.34%
-3.6951
|
-3.5077 | -4.1072 | -8.5315 | -4.0559 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
11.40%
-0.0385
|
-0.0435 | - | -2.1592 | -0.2308 |
Basic Average Shares |
0.00%
5.0525
|
5.0525 | 4.9591 | -33.31 | 39.44 |
Diluted Average Shares |
0.00%
5.0525
|
5.0525 | -0.0464 | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):